Cargando…

Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis

Detalles Bibliográficos
Autores principales:	Guilherme, Enrique, Jacquet-Lagrèze, Matthias, Pozzi, Matteo, Achana, Felix, Armoiry, Xavier, Fellahi, Jean-Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409465/ https://www.ncbi.nlm.nih.gov/pubmed/32758275 http://dx.doi.org/10.1186/s13054-020-03213-w

Ejemplares similares

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Levosimendan for VA‐ECMO weaning: the silver lining
por: Kaddoura, Rasha, et al.
Publicado: (2021)

Functional evaluation of sublingual microcirculation indicates successful weaning from VA-ECMO in cardiogenic shock
por: Akin, Sakir, et al.
Publicado: (2017)

Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
por: Chen, Yu-Wen, et al.
Publicado: (2022)

Should ECMO be used in cardiogenic shock?
por: Gokalp, Orhan, et al.
Publicado: (2019)

ECMO in cardiac arrest and cardiogenic shock
por: Napp, L. C., et al.
Publicado: (2017)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Postcardiotomy VA-ECMO for refractory cardiogenic shock
por: Charlesworth, Michael, et al.
Publicado: (2017)

Use of ECMO for Cardiogenic Shock in Pediatric Population
por: Bhaskar, Priya, et al.
Publicado: (2021)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial
por: Ellouze, Omar, et al.
Publicado: (2021)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

Do we need another prognostic score for cardiogenic shock patients with ECMO?
por: Champion, Sébastien
Publicado: (2017)

ECMO Support in Refractory Cardiogenic Shock: Risk Factors for Mortality
por: Rajsic, Sasa, et al.
Publicado: (2022)

Extracorporeal Membrane Oxygenation (VA-ECMO) in Management of Cardiogenic Shock
por: Koziol, Klaudia J., et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Predicting Survival After VA-ECMO for Refractory Cardiogenic Shock: Validating the SAVE Score
por: Amin, Faizan, et al.
Publicado: (2020)

Multiparameters Associated to Successful Weaning from VA ECMO in Adult Patients with Cardiogenic Shock or Cardiac Arrest: Systematic Review and Meta-Analysis
por: Burgos, Lucrecia María, et al.
Publicado: (2023)

ECMO in Cardiogenic Shock: Time Course of Blood Biomarkers and Associated Mortality
por: Rajsic, Sasa, et al.
Publicado: (2022)

Noninferiority trials: a specific design with a particular methodology
por: Ruste, Martin, et al.
Publicado: (2022)

Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis
por: Moussa, Mouhamed Djahoum, et al.
Publicado: (2022)

Improving the prognostic value of ∆PCO(2) following cardiac surgery: a prospective pilot study
por: Portran, Philippe, et al.
Publicado: (2019)

In-hospital and long-term mortality after venoarterial ECMO for refractory cardiogenic shock
por: Bottiroli, M, et al.
Publicado: (2015)

Blood lactate normalization following venoarterial ECMO institution for refractory cardiogenic shock
por: Bottiroli, M, et al.
Publicado: (2015)

Surgical outcomes in cardiogenic shock patients with preoperative extracorporeal membrane oxygenation (ECMO)
por: Abuharb, Mahmoud Yousef Ibrahim, et al.
Publicado: (2021)

Cardiogenic Shock in COVID 19 Fulminant Myocarditis Treated with V-A ECMO
por: D'Errico Ramirez, A., et al.
Publicado: (2022)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Fluid removal tolerance during the de-escalation phase: is preload unresponsiveness the best guiding candidate?
por: Ruste, Martin, et al.
Publicado: (2023)

Comparison of the Efficacy of ECMO With or Without IABP in Patients With Cardiogenic Shock: A Meta-Analysis
por: Zeng, Ping, et al.
Publicado: (2022)

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
por: Omerovic, Elmir, et al.
Publicado: (2010)

Ultrasound Assessment in Cardiogenic Shock Weaning: A Review of the State of the Art
por: Muñoz-Rodríguez, Rebeca, et al.
Publicado: (2021)

Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
por: Wernly, Bernhard, et al.
Publicado: (2021)

Effective Treatment of Acute Tricyclic Antidepressant Poisoning with Cardiogenic Shock and Severe Rhabdomyolysis Using ECMO and CytoSorb(®) Adsorber
por: Zitoune, Zakaria, et al.
Publicado: (2023)

Addition of levosimendan to overcome acute cardiogenic shock—Paving the way for later heart transplantation—A first case report
por: Flottmann, Christian, et al.
Publicado: (2020)

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report
por: Fox, Henrik, et al.
Publicado: (2022)

Extracorporeal membrane oxygenation (ECMO) in the management of non-surgical patients with cardiogenic shock and cardiac arrest
por: Ostadal, P, et al.
Publicado: (2015)

Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy Plus Apical Ballooning: Management With VA-ECMO and Myectomy
por: Caniato, Flavia, et al.
Publicado: (2021)

Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock
por: Tsangaris, Adamantios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s8nbvamopb5a7n8roffs6nu3t6